BCG installations for bladder cancer and latent tuberculosis infection.
Hanson
Karen
K
Mayo Clinic, Rochester, MN, USA.
D000276:Adjuvants, Immunologic / Q000008:administration & dosage* / Q000009:adverse effects; D000283:Administration, Intravesical; D001500:BCG Vaccine / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D014376:Tuberculosis / Q000209:etiology; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine